Dermal Laboratories Revenue and Competitors
Estimated Revenue & Valuation
- Dermal Laboratories's estimated annual revenue is currently $27.7M per year.
- Dermal Laboratories's estimated revenue per employee is $201,000
Employee Data
- Dermal Laboratories has 138 Employees.
- Dermal Laboratories grew their employee count by 0% last year.
Dermal Laboratories's People
Name | Title | Email/Phone |
---|
Dermal Laboratories Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $58.9M | 293 | 6% | N/A | N/A |
#2 | $21.1M | 105 | 5% | N/A | N/A |
#3 | $113.4M | 564 | 1% | N/A | N/A |
#4 | $20.9M | 104 | -5% | N/A | N/A |
#5 | $37M | 184 | 9% | N/A | N/A |
#6 | $45.4M | 226 | -24% | N/A | N/A |
#7 | $16.1M | N/A | N/A | N/A | |
#8 | $69.7M | 347 | 0% | N/A | N/A |
#9 | $8M | 40 | 3% | N/A | N/A |
#10 | $25.5M | 127 | 28% | N/A | N/A |
What Is Dermal Laboratories?
Dermal Laboratories Limited is a pharmaceuticals company based out of Old Station Rd, Loughton, United Kingdom.
keywords:N/AN/A
Total Funding
138
Number of Employees
$27.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Dermal Laboratories News
2022-04-20 - Global Injectable Dermal Fillers Market 2022 Top Companies ...
Global Injectable Dermal Fillers Market 2022 Top Companies, New Technology, Demand and Opportunity ALLERGAN, Merz Pharma, Galderma laboratories, Sinclair...
2022-04-17 - Hyaluronic Acid Based Dermal Fillers Market Size, Scope And ...
... Suneva Medicals, LG Life Sciences, Galderma Laboratories L.P., Candela Corporation. This Hyaluronic Acid Based Dermal Fillers Market...
2022-04-13 - Dermal Fillers Market Trends, Leading Players, Business ...
Dermal Filler Market Competitive Dynamics. The notable players of the market are Galderma Laboratories, LP (Switzerland), Allergan (Ireland)...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $19.4M | 147 | 21% | N/A |
#2 | $32.7M | 165 | 0% | N/A |
#3 | $67.7M | 361 | 1% | N/A |
#4 | $66.9M | 446 | N/A | N/A |
#5 | $263.1M | 828 | 4% | N/A |